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Successful healing of skin wounds requires sensory innervation and the release of vasoactive neuropeptides that dilate blood vessels and
deliver serum proteins to the wound, and that cause pain that protects from further injury. Activin has been proposed as a target-derived
regulator of sensory neuropeptides during development, but its role in the mature nervous system is unknown. While adult skin contains a
low level of activin, protein levels in skin adjacent to a wound increase rapidly after an excision. Neurons containing the neuropeptide
calcitonin gene-related peptide (CGRP) increased in sensory ganglia that projected to the wounded skin, but not in ganglia that projected to
unwounded skin, suggesting that neurons respond to a local skin signal. Indeed, many adult sensory neurons respond with increased CGRP
expression to the application of activin in vitro and utilize a smad-mediated signal transduction pathway in this response. A second skin-
derived factor nerve growth factor (NGF) also increased in wounded skin and increased CGRP in cultured adult dorsal root ganglia (DRG)
neurons but with lower efficacy. Together, these data support the hypothesis that activin made by skin cells regulates changes in sensory
neuropeptides following skin injury, thereby promoting vasodilation and wound healing.
D 2004 Elsevier Inc. All rights reserved.Keywords: Dorsal root ganglion; Sensory neuron; Activin; Transforming growth factor h; Bone morphogenetic protein; Calcitonin gene-related peptide;
Target-derived; Smad; Skin wound
Introduction irritants, where CGRP causes peripheral vasodilation (BrainSkin injury or inflammation results in both rapid local
vasodilation caused by the sensory neuropeptides calcitonin
gene-related peptide (CGRP) and substance P (SP), and
longer-term upregulation of these neuropeptides in both skin
and spinal ganglia. These neuropeptides are present in
cutaneous sensory nerve terminals and are released centrally
and peripherally during pain transduction (Holzer, 1988; Ju et
al., 1987; Lee et al., 1985; Molander et al., 1987; O’Brien et
al., 1989; Skofitsch and Jacobowitz, 1985). Multiple neuro-
peptides are normally present in small- and medium-sized
sensory neurons that innervate skin, blood vessels, and gut,
but are absent from larger-sized proprioceptive neurons that
innervate muscle spindles. CGRP and SP are also released
from sensory nerves in response to physical or chemical0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.04.003
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E-mail address: axh8@cwru.edu (A.K. Hall).et al., 1985; Wallengren and Hakanson, 1987). Neuropeptide
increases in the innervating dorsal root ganglia (DRG) occur
following target tissue damage (Mulder et al., 1997), includ-
ing arthritis (Hanesch et al., 1993). These increased neuro-
peptides are key biological responses, because neuropeptides
and sensory innervation in general are required for successful
wound healing (Kjartansson and Dalsgaard, 1987; Kjartans-
son et al., 1987). What is not well understood is how skin
signals regulate sensory neuropeptides after a skin wound.
Previous work identified the TGFh superfamily member
activin as an important regulator of sensory vasoactive
neuropeptide differentiation in embryonic sensory neurons
(Ai et al., 1999; Hall et al., 2001), but the role of this ligand
in adult neuropeptide regulation is not clear. The TGFh
superfamily comprises a large group of related ligands that
have pleiomorphic effects in development (for review, see
Hogan, 1996; Kingsley, 1994; Massague´ and Chen, 2002;
Mehler et al., 1997). Activin signals through a heteromeric
receptor complex and activates the transcription factors
smad2 and smad3. Once activated, these smads become
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transcription (for review, see Heldin et al., 1997; Zhu and
Burgess, 2001). Skin-conditioned medium or exogenous
activin induces CGRP expression in embryonic sensory
neurons (Ai et al., 1999; Hall et al., 2001) and activin is
present in embryonic skin (Hall et al., 2002), suggesting that
activin is a target-derived differentiation factor for develop-
ing sensory neurons. Activin mRNA is not detected in the
skin of adult mice (Hu¨bner et al., 1996), suggesting the
ligand is not responsible for the maintenance of CGRP
expression in adult DRG. By contrast, excisional skin
wounds result in dramatic activin mRNA induction in
adjacent skin (Hu¨bner et al., 1996), which is thought to
affect healing of the skin itself. The present study was
designed to learn if such changes in skin activin following
a wound affected not only local skin but also the innervating
sensory neurons. Here we show that activin protein levels in
adult skin increase following an excisional skin wound, that
CGRP expression increases in the innervating sensory
ganglia, and that adult neurons respond directly to activin
stimulation in vitro via smad transcription factor activation.
Nerve growth factor (NGF) can also affect sensory neuro-
peptide levels (Lindsay and Harmar, 1989), and we com-
pared the expression and effects of activin and NGF. We
propose that wounded skin upregulates activin in skin that
signals cutaneous sensory neurons to increase CGRP, a
change that results in increased vasodilation and delivery
of serum proteins essential for successful wound healing.Materials and methods
Skin wound and DRG analysis
Adult female Sprague–Dawley rats (8–10 weeks old,
Zivic Miller) were deeply anesthetized by intraperitoneal
injection (150 Al) of a cocktail of 100 mg/ml ketamine, 20
mg/ml xylazine, and 10 mg/ml acepromazine (obtained
from the University Animal Resource Center). Each animal
received eight 4-mm circular-square full thickness skin
excisions along the L4 and L5 dermatomes in the left hind
limb. For each excision, the full thickness of the skin,
including the epidermis and dermis, was completely re-
moved, leaving the fascia and muscle exposed. Schematic
maps of rat dermatomes are based on antidromic C-fiber
stimulation of dorsal root and extravasation of Evans Blue
(unpublished observations, Dr. Carl Molander, Karolinska
Institute, Stockholm). Following excision, wounds were left
uncovered. Wounded animals moved, ate, and slept in a
manner indistinguishable from unwounded animals. After 2
days, the 1–2 mm of skin surrounding the wounds, but not
the scab, was collected. Skin from the unwounded hind
limb as well as corresponding amounts of skin from
unwounded animals served as controls. The fourth and fifth
lumbar dorsal root ganglia (DRG) both contralateral and
ipsilateral to the wound were collected. Ganglia were fixedfor 2.5 h in 4% paraformaldehyde in 0.1 M PO4, then
cryoprotected overnight in 30% sucrose in PO4 buffer at
4jC before sectioning. Three independent experiments were
performed, with six animals in each of two experiments
(two control/four wound) and eight animals in the third
(three control/five wound). All experiments with animals
were reviewed and carried out in accordance with the
Institutional Animal Care and Use Committee at Case
Western Reserve University.
Immunohistochemistry
Frozen sections (10 Am) from each DRG were collected
on 10 sequential slides, such that adjacent sections on a slide
were 100 Am apart, and stored at 20jC until use. DRG
sections were washed in phosphate-buffered saline (PBS)
and incubated for 1 h at room temperature in blocking
solution (0.3% Tween 20, 0.2% Triton X-100, 3% bovine
serum albumin (BSA, Sigma, St. Louis, MO) in PBS).
Sections were then incubated overnight at 4jC in primary
antibody diluted in blocking solution. Antibodies included
the neuronal nuclear marker mouse anti-Islet-1 (Avivi and
Goldstein, 1999; 1:10, 39.4, Developmental Studies Hy-
bridoma Bank, University of Iowa), rabbit anti-CGRP
(1:4000, Sigma), or rabbit anti-Substance P (1:250, Incstar,
Stillwater, MN). CGRP and SP signals were amplified by
incubation with a biotin-conjugated anti-rabbit IgG diluted
in blocking solution (1:300, Chemicon, Temecula, CA) for
1.5 h at room temperature, followed by incubation with a
Cy2-conjugated Streptavidin diluted in PBS (1:800, Jackson
Immunoresearch, West Grove, PA) for 1 h at room temper-
ature. The primary antibody was omitted in control studies.
Islet-1 was visualized by incubation with a Cy3-labeled
anti-mouse IgG diluted in blocking solution (1:200, Jackson
Immunoresearch). After washing, sections were mounted in
2% n-propyl gallate in 50% glycerol–PBS. All nuclei of
cells that stained positive for Islet-1 were counted, and of
these neurons, those that were CGRP positive were scored.
Sections (10 Am) of 100 Am apart for both ipsilateral and
contralateral DRG from five unwounded and nine wounded
animals were assayed, with at least 1000 neurons counted
for each DRG. Statistical analyses were done using Statview
4.1 software with an unpaired t test.
Adult skin was fresh frozen and 20-Am thick transverse
frozen sections were collected and stored at 20jC until
use. Sections were placed in 20jC acetone for 20 min, air
dried for an additional 20 min, and incubated overnight at
4jC in primary antibodies: goat anti-activin (1:50 dilution,
R&D Systems, Minneapolis, MN) and mouse pan-cytoker-
atin (1:100, Sigma) in dilution buffer that contained 0.3%
Triton X-100–PBS and 2% BSA. After washing, sections
were incubated in biotinylated donkey anti-goat IgG (1:200,
Jackson Immunoresearch) and Cy2-conjugated goat anti-
mouse IgG (1:200, Jackson Immunoresearch) in the same
dilution buffer for 2 h at room temperature. Sections were
washed and reacted with 1:750 dilution of Cy3-conjugated
B.A. Cruise et al. / Developmental Biology 271 (2004) 1–10 3streptavidin (Jackson Immunoresearch) for 1 h, then washed
and mounted in 2% n-propyl gallate in 50% glycerol–PBS
to prevent photobleaching.
Immunoblot lysates
Normal or wounded rat skin was homogenized on ice in
9-fold volume of lysis buffer containing 20 mM Tris, 0.1 M
NaCl, 0.5 mM EDTA, 10% glycerol, 1% NP-40, one-tenth
volume protease inhibitor cocktail (Sigma). For smad im-
munoblot lysates, DRG neurons were dissociated and plated
as described below, except cells were cultured in 24-well
plates with 8000 cells/1.88 cm2. After 3 days in defined
neurobasal medium alone (see below), 20 ng/ml activin was
added for 1 h at 37jC. The cells were then lysed in 40
Al lysis buffer above. For all samples, insoluble material was
removed by centrifugation, and the supernatant collected
and stored at 20jC until use. Protein concentrations were
determined by Peterson’s modified assay (Sigma).
Western blot analysis
Total protein (10–15 Ag) per lane in SDS-PAGE sample
buffer (0.125 M Tris, 20% glycerol, 10% h-mercaptoetha-
nol, 4% sodium dodecyl sulfate, and 0.001% bromophenol
blue) was boiled at 95jC for 5 min to reduce the proteins.
The samples were run on a 15% 8  6 cm polyacrylamide
gel under reducing conditions according to Laemmli (1970).
Recombinant protein standards were used as positive con-
trols (1 ng NGF, Austral Biologicals, San Ramon, CA; 2 ng
human Activin A, R&D Systems). Proteins were transferred
onto PVDF membrane (NEN, Boston, MA) for approxi-
mately 170 V-h. Nonspecific binding sites were blocked by
incubation in 6% BSA in Tris-buffered saline (TBS) plus
0.2% Tween 20 for at least 6 h at 4jC. Membranes were
incubated overnight at 4jC in appropriate primary antibody
diluted in blocking solution: goat anti-recombinant human
Activin A (1:400, R&D Systems) or rabbit anti-NGF
(1:10,000, Sigma). As previously described, the activin
antibody used in these experiments reacted only with the
specified recombinant ligand (Hall et al., 2001). Primary
antibody was omitted in control studies, and specific signal
was absent. Following washes in TBS–Tween, membranes
were incubated for 2 h at room temperature in appropriate
peroxidase-conjugated secondary antibodies diluted in
blocking solution: donkey anti-goat IgG (1:2000, Jackson
Immunoresearch) or goat anti-rabbit IgG (1:2500, Jackson
Immunoresearch). Membranes were washed and proteins
visualized using a chemiluminescent substrate for horserad-
ish peroxidase (SuperSignal West Pico, Pierce Chemicals,
Rockford, IL) on Hyperfilm ECL (Amersham Pharmacia
Biotech, Piscataway, NJ).
For Smad immunoblots, proteins from lysed DRG neu-
rons were similarly separated by electrophoresis, but then
transferred to nitrocellulose for approximately 170 V-h.
Nitrocellulose was washed, then nonspecific sites wereblocked for 30 min at room temperature in 5% nonfat dry
milk, 0.05% Tween 20 in TBS before incubation overnight
at 4jC in primary antibody diluted in blocking solution:
rabbit anti-Smad2–PO4 (1:400, United States Biological,
Swampscott, MA). Following washes in deionized distilled
water, the nitrocellulose was incubated 1.5 h at room
temperature in appropriate peroxidase-conjugated secondary
antibody: goat anti-rabbit peroxidase IgG (1:2500, Upstate
Biotechnology, Lake Placid, NY, same diluent). Nitrocellu-
lose was washed with water and then briefly washed with
0.05% Tween 20 in TBS before visualizing proteins using
the chemiluminescent substrate as described above. In some
cases, membranes were stripped in 100 mM h-mercapto-
ethanol, 2% SDS, 62.5 mM Tris–HCL for 30 min at 50jC.
Membranes were washed, incubated in blocking solution for
at least 2 h at room temperature, then incubated overnight at
4jC in goat anti-actin antibody (1:12,000, Santa Cruz
Biotechnology, Santa Cruz, CA) followed by incubation in
peroxidase-linked secondary antibody (donkey anti-goat
peroxidase, 1:2000, Jackson Immunoresearch), and washed
and visualized as described above.
Adult DRG cell culture
Adult rat lumbar DRGs were collected on ice in Hank’s
Balanced Salt Solution (HBSS, Sigma), desheathed, and
dissociated in dispase (2.5 u/ml, Roche Molecular Biochem-
icals, Indianapolis, IN)/collagenase (200 u/ml, Worthington
Biochemical Corporation, Lakewood, NJ) in HBSS for 1
h 45 min at room temperature. Two thousand four hundred
cells per 0.32 cm2 were grown in 96-well plates coated with
poly-L-lysine and 2 Ag/ml laminin (Biomedical Technolo-
gies, Inc, Stoughton, MA) and maintained in defined neuro-
basal medium (Gibco-BRL) with B27 medium supplement
(Gibco-BRL), penicillin– streptomycin (1:200, Gibco-
BRL), 3 mM glutamine (unless otherwise specified). Cells
were cultured for 3 days in defined neurobasal medium
alone before addition of factors. Recombinant Activin A
(1–20 ng/ml, R&D Systems) or NGF (1–100 ng/ml,
Austral) was added for three additional days. In some
cultures, FudR (5 AM, Sigma) was added to deplete non-
neuronal cells.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde in 0.1 M
phosphate buffer for 2 h at room temperature, then fixed
in ice-cold 95% methanol–5% glacial acetic acid for 15 min
at 20jC. After rinsing in PBS, cultures were incubated in
0.4% Triton X-100 in PBS for 1 h at room temperature
before incubation overnight at 4jC in primary antibody
diluted in 0.4% Triton–PBS with 20% goat serum (rabbit
anti-CGRP, 1:4000, Sigma; rabbit anti-SP, 1:250, Incstar).
Following rinsing, cultures were incubated for 1.5 h at room
temperature in biotin-conjugated goat anti-rabbit IgG
(1:250, Chemicon). CGRP expression was visualized using
Fig. 2. Activin A and NGF proteins increase in skin following wound.
Western blot analyses of skin lysates to identify activin A (top panel) or
NGF (middle panel) in skin from each control or wounded animal.
Recombinant activin A (2 ng, std lane) has Mr 14 kDa. Low levels of
activin A are present in control unwounded skin samples (Control lanes)
and after wound, activin A levels increased in each wounded animal
(Wound lanes). Recombinant NGF (1 ng, std lane) appears at Mr 13 kDa.
Low levels of NGF are present in unwounded skin. NGF protein levels
increased following skin wound in each animal. When primary antibody
was omitted, no reactivity was seen (No 1). As a loading control, the activin
blot was stripped and reprobed for actin (lower panel) to demonstrate that
similar amounts of protein were present. Similar results were seen in three
independent experiments, with six animals in each of two experiments (two
control/four wound) and eight animals in the third (three control/five
wound).
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diaminobenzidine chromogen. The percentage of total neu-
rons that was CGRP positive was determined. Cells were
scored based on intensity of staining (negative to light,
medium, dark). A minimum of 250 cells per well was
counted and only cells that scored medium to dark staining
above background levels were included in the analysis. At
least 3 wells per experiment were quantified for each
condition from three independent experiments except the
NGF dose response, done in duplicate. Statistical analyses
were done using Statview 4.1 software with unpaired t tests.
For smad2 translocation or phospho-smad2 immunocyto-
chemistry, adult sensory neurons were dissociated and
cultured as described above, except cells were grown on
coverslips in 24-well plates at 8000 cells/1.88 cm2. After 3
days, neurons were stimulated with 20 ng/ml activin for 1
h at 37jC. The defined medium alone served as control.
Cells were fixed in 4% paraformaldehyde for 30 min at
room temperature, then in 95% methanol–5% acetic acid
for 12 min at 20jC. After washing in PBS, cells were
reacted with antibodies to either smad 2 (1:250; Upstate
Biotechnology) or phospho-specific smad2 (Smad2–PO4,
1:500; United States Biologicals) followed by biotin-conju-
gated secondary antibody (1:300, Chemicon) and then Cy2-
conjugated streptavidin (1:800, Jackson Immunoresearch).
Coverslips were then mounted in 2% n-propyl gallate in
50% glycerol–PBS. Smad2 translocation immunostaining
was performed in one experiment, and smad2 P04 immu-
nostaining was done in six independent experiments.Results
Both sensory innervation and the release of vasoactive
neuropeptides in the skin are crucial for successful skinFig. 1. Experimental paradigm. Four full thickness excisional skin wounds
were made in both the L4 and L5 dermatomes of one hind limb of an adult
rat. Two days later, the healing skin was collected for Western immunoblot,
and the innervating DRG analyzed for the proportion of CGRP- and Islet-1-
expressing neurons.wound healing. Previous work identified activin as an
important regulator of sensory vasoactive neuropeptide dif-
ferentiation in embryonic sensory neurons (Ai et al., 1999;
Hall et al., 2001) and demonstrated that activin mRNA
increased following skin wound (Hu¨bner et al., 1996), yet
the role of activin in adult neuropeptide regulation is not
clear. The present study was designed to learn if changes in
skin activin following a wound affected not only local skin
but also the innervating sensory neurons. To examine activin
and CGRP changes after skin wounds, full thickness exci-
sional skin wounds were made in one hind limb of adult rats
along the fourth and fifth lumbar dermatomes (Fig. 1). Two
days later, the skin surrounding each wound was collected
and analyzed for the presence of activin and NGF via
Western blot. In addition, the lumbar DRGs that innervate
the wounded skin region were analyzed for changes in
vasoactive neuropeptides. Further, the ability of activin to
increase CGRP in dissociated adult neurons was tested. Our
results suggest that activin from a skin wound acts on
innervating sensory neurons to increase neuropeptides.
Excisional skin wounds increased activin expression in
surrounding, healing skin. Although activin A is present in
embryonic skin (Hall et al., 2002), activin mRNA is difficult
to detect in unperturbed adult skin (Hu¨bner et al., 1996).
Following a skin wound, the amount of activin protein
increased in skin at 2 days (Fig. 2, top panel, wound lanes),
but did not increased in unaffected skin on the opposite leg of
the same animal or in unwounded animals. Activin is
expressed in the epidermal keratinocytes of the skin at the
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affect sensory neuropeptide levels and increases in skin
following inflammation (Lindsay and Harmar, 1989; Mal-
cangio et al., 1997; Woolf et al., 1994), unwounded and
wounded skin were also analyzed for changes in NGF
expression. As expected, very low levels of NGF were
present in unwounded adult skin, and NGF also increased
in adjacent skin following the wound (Fig. 2, middle panel).
Thus, a skin wound induces local changes in expression of
skin ligands.
To test if the skin wound affected sensory neuropeptides,
the corresponding fourth and fifth lumbar DRGs on either
the wounded side (ipsilateral) or on the opposite side
(contralateral) of the animal were analyzed for CGRP and
SP expression. DRG sections were reacted with antibodies
to the transcription factor Islet-1 to identify the nuclei of all
neurons (Avivi and Goldstein, 1999) and a CGRP antibody
to identify the neuropeptide-containing sensory neurons
that include nociceptors (Fig. 4A, arrows). As expected,
Islet-1 antibody identified comparable proportions of DRGFig. 3. Activin is expressed in keratinocytes. (A) Low magnification of skin
2 days following minor wounds caused by full thickness incisions (arrows).
Scale bar: 100 Am. (B–G) Higher magnification of skin 2 days following
large excisional wounds. (B and D) Anti-activin. (C and E) Anti-
cytokeratin. While normal skin has light activin reactivity, activin is highly
expressed in responding keratinocytes at the wound margin. These
epidermal cells also react with anti-cytokeratin. (F and G) When primary
antibody is omitted, no specific staining is seen at wound. Scale bar: 25 Am.
Fig. 4. CGRP-immunoreactive neurons increase in DRGs that innervate the
skin wounds. (A) Only neurons with an Islet-1-immunoreactive nucleus
were counted as neurons and evaluated for CGRP expression. CGRP-
immunoreactive (arrows) and CGRP-deficient neurons (arrowheads) were
identified and quantified as a percentage of total neuron number. (B) The
percentage of CGRP-positive neurons in the L4 DRG of unwounded
animals (black bars) was 24.2 F 1.45 SEM in 7729 neurons counted from
five animals, while in the L5 DRG of these animals 24.2 F 1.59 SEM
neurons were CGRP immunoreactive in 8312 neurons counted (black
bars). The percentage of CGRP immunoreactive neurons was normalized
to these control values, and in DRG ipsilateral to the wound, a 37.1 F
5.1% increase in CGRP-containing neurons was observed in L4 ganglia
and a 32.2 F 7.4% increase observed in L5 ganglia (L4, 9020 neurons
counted, P = 0.01; L5, 11,256 neurons counted, P = 0.017; nine wounded
animals counted), while there was no change in DRG contralateral to the
wound (L4, 9995 neurons counted, P = 0.23; L5, 10,517 neurons counted;
P = 0.51).neurons in control and wounded animals. About one-fourth
of DRG neurons were CGRP-positive in unwounded ani-
mals (Fig. 4B, L4 DRG 24.2 F 1.45% (n = 7729); L5 DRG
24.2 F 1.59% (n = 8312)), and both the right and left
DRGs of unwounded animals contained similar proportions
of CGRP-immunoreactive neurons, as expected (Fig. 4B,
black bars). In contrast, the DRG ipsilateral to the wounded
side demonstrated a 37.1 F 5.1% increase in the proportion
of CGRP-containing neurons in L4 ganglia and a 32.2 F
7.4% increase in L5 ganglia (Fig. 4B, gray bars, P = 0.01
and P = 0.017, respectively). Further, because skin injury
was performed on only one side of the animal, the
proportion of CGRP-containing neurons was unchanged
in the DRG opposite the wound, suggesting that the wound
did not produce a systemic effect. Thus, the excisional skin
wound increased CGRP expression in the neurons of the
innervating DRG.
The increased activin in wounded skin and increased
CGRP in corresponding DRG suggest that skin activin
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adult DRG neurons were examined for their ability to
respond to activin or NGF stimulation in vitro. Neurons
were maintained for 3 days in defined medium to recover
from axotomy, then stimulated with activin or NGF for an
additional 3 days. In control cultures, about 30% of neurons
maintained in defined medium had detectable CGRP ex-
pression (Fig. 5), a proportion similar to that seen in vivo
(Scott, 1992). Activin stimulation increased the percentage
of CGRP-expressing neurons in a dose-dependent manner,
such that 39.5 F 1.11% of neurons expressed CGRP with
20 ng/ml activin (Fig. 5C, P < 0.0001). The addition of
NGF to adult neurons in vitro also induced CGRP expres-Fig. 5. Activin addition increases CGRP-immunoreactive neurons in adult
DRG neurons in vitro. Approximately 30% of neurons cultured in basal
medium alone were CGRP immunoreactive (A), while CGRP neurons
increased after activin addition (B). Activin stimulated CGRP expression in
adult DRG cultures in a concentration-dependent manner, with 20 ng/ml
increasing CGRP neurons to 39.5 F 1.11% of all neurons (C). The addition
of 1–100 ng/ml NGF increased CGRP-immunoreactive adult DRG neurons
to 38.6 F 1.04%, with maximal induction seen at a concentration of 50 ng/
ml NGF (D). In cultures treated with FudR to deplete nonneuronal cells,
activin still increased CGRP-immunoreactive neurons (E, 39.6 F 1.19%).
The addition of 20 ng/ml activin before 50 ng/ml NGF, addition in reverse
order, or addition of both factors simultaneously increased CGRP-
immunoreactive neurons to levels equal to activin alone (F). Data represent
means and SEM from three independent experiments done in triplicate,
except NGF dose response, done in duplicate. *P V 0.02, **P V 0.003,
***P V 0.0003.
Fig. 6. Intracellular smad2 phosphorylation and translocation in neurons
following activin stimulation. Dissociated adult DRGs were grown for 3
days in basal medium, and then stimulated for 1 h with 20 ng/ml activin.
Cells were lysed and assayed for total smad 2 and phospho-specific smad 2
(top panel). Similar levels of total smad2 were present in treated (+A) and
control (C) cultures, while activated phospho-specific smad2 was present
only after activin stimulation (+A). To identify which cells responded to
activin, cultures were stained with antibody to smad2 (A and B) or phospho-
specific smad2 (C and D). Following 1-h activin stimulation, many neurons
had smad2 translocation into the nucleus (arrowheads, A and B), and
phospho-specific smad2–PO4-immunoreactivity was localized in neuronal
nuclei (C and D, arrowheads). Phospho-smad2 was present in 20.7 F 5%
neurons in control cultures and 91 F 5% neurons after activin stimulation
(200 cells counted in each of six experiments).sion in a dose-dependent manner (Fig. 5D), but substantially
higher concentration of ligand was required to produce an
increase (50 ng/ml NGF, 38.6 F 1.04%, P = 0.001). Activin
stimulation produced robust CGRP induction at lower con-
centrations, suggesting that although neurons are capable of
responding to multiple stimuli in vitro, activin may be
playing the dominant role in CGRP induction. In some
cases, adult neurons were treated with 5 AM FudR during
the culture period to deplete nonneuronal cells. These
neurons also responded to activin in a dose-dependent
manner (Fig. 5E). To test if activin treatment potentiated
NGF effects, 20 ng/ml activin was added for 2 days,
followed by 50 ng/ml NGF for 1–2 days, or factors were
added in the reverse order, or simultaneously, and CGRP-
expressing neurons quantified (Fig. 5F). Activin added in
addition to NGF, together or in either order, had equivalent
effects to the addition of activin alone, indicating that these
factors act on the same responsive neuronal population.
To assay if adult neurons respond directly to activin, the
smad intracellular signaling cascade that mediates intracel-
lular signals from activin was investigated in adult DRG
neurons. In complete cultures, under basal conditions, there
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ment, there was strong induction of smad2–PO4 detected on
immunoblots (Fig. 6, upper panel). Total smad2 levels
remained unchanged after stimulation, suggesting that exist-
ing pools of smad2 become activated in response to activin.
These data indicate that a phosphorylated signal was gen-
erated after ligand binding, but the cellular location of the
activated smad was unclear. The addition of activin for 1
h resulted in the translocation of smad2 from the cytoplasm
to the nucleus in stimulated but not control cultures (Figs.
6A and B). Further, using antibody specific for phosphor-
ylated smad2, few neurons had nuclear smad2–PO4 (Fig.
6C) under basal conditions, while most had nuclear smad2–
PO4 after 1-h activin treatment (Fig. 6D, 20.7 F 5% basal
level; 91 F 5% after activin stimulation, six experiments).
Nonneuronal cells in these cultures did not show significant
smad immunoreactivity or translocation, suggesting their
trophic function observed by FudR studies above is not
mediated by smads. Taken together, these data demonstrate
that adult neurons alter their neuropeptide content in re-
sponse to increases in activin that occur during the wound
healing process.Discussion
While skin wound healing might initially be considered a
local event involving only intrinsic skin cells, successful
healing actually requires sensory innervation and delivery of
vasoactive neuropeptides to the skin (Holzer, 1988; Kjar-
tansson and Dalsgaard, 1987; Kjartansson et al., 1987;
Wallengren and Hakanson, 1987). The present study dem-
onstrates that neuropeptide increases in DRG neurons occur
after skin wounds as they do following inflammation
(Mulder et al., 1997) and arthritis (Hanesch et al., 1993).
Further, healing skin was shown to have increased levels of
activin protein. Activin is capable of inducing adult DRG
neurons to become CGRP-immunoreactive in vitro, support-
ing the notion that the receptors and signaling mechanisms
required for these ligands to act are still present on many
adult neurons. Indeed, smad transcription factor activation
and translocation occur rapidly after activin addition in these
cells. These novel observations highlight activin as a key
regulator of neuropeptides in adult sensory neurons
responding to a skin wound.
Several experimental paradigms are currently used to
study sensory neurons after injury, and each manipulation is
associated with distinct neuropeptide changes. The wound
paradigm used in this study excises some target skin and is
associated with increased CGRP expression in the innervat-
ing DRG. This increase in CGRP following a skin wound
differs from the decreases in CGRP, SP, and somatostatin in
the DRG after the nerve is cut (Villar et al., 1991; Zhang et
al., 1996). Loss of target-derived factors such as NGF or
presentation of nonneuronal cell-derived injury factors is
thought to underlie the neuropeptide changes that followaxotomy (Fizgerald et al., 1985; Zigmond, 1997; Zigmond
et al., 1995). A third manipulation, skin inflammation,
involves injection of chemical irritants under the skin and
is also associated with increased CGRP and SP in the
innervating DRG (Neumann et al., 1996). Skin inflamma-
tion increases NGF expression in the periphery, and NGF
increases can alter sensory neuropeptide content (Donnerer
et al., 1992; Lindsay and Harmar, 1989; Woolf et al., 1994).
However, systemic administration of anti-NGF reagents
only partially blocks the increase in DRG neuropeptides
after inflammation (Donnerer et al., 1992; Woolf et al.,
1994). These data suggest that while NGF is involved in
some neuropeptide changes, other molecules may play
additional roles.
This is the first report of activin’s ability to regulate
CGRP expression in adult neurons. During embryogenesis,
we propose that activin is a skin-derived differentiation
factor (Hall et al., 2001, 2002). Indeed, expression of activin
and other TGFh family members is widespread in embryonic
target tissues and may be focused by co-expression of
inhibitory factors or additional growth factors. For example,
BMPs and neurotrophic factors exhibit some synergism in
survival-promoting activity in sensory neurons (Farkas et al.,
1999). Although induction of CGRP expression in develop-
ing sensory neurons involves target-derived activin, low
levels of activin in normal adult skin suggest that activin
does not maintain neuropeptide expression (this report,
Hu¨bner et al., 1996). Increased activin in wounded adult
skin may in part recapitulate the inductive role activin has on
CGRP expression in sensory neurons. Unlike embryonic
neurons, adult DRG neurons have already made functional
connections with their target tissues, and about 30% of these
neurons normally express CGRP in vivo (Scott, 1992).
Similarly, one-third of adult neurons maintained in defined
medium were CGRP-immunoreactive under control condi-
tions, while 40% expressed CGRP after addition of activin.
Adult neurons responded to activin in a dose-dependent
manner and rapidly activated smad transcription factors upon
ligand addition, indicating that activin acts directly on these
neurons, and that some adult neurons continue to exhibit
phenotypic plasticity. A comparison of activin’s effects on
embryonic and adult DRG neurons indicates that CGRP
induction in adult neurons required higher concentrations of
ligand and fewer neurons were capable of acquiring CGRP
expression. Pilot studies suggest that 50 ng/ml activin is less
effective at CGRP induction in adult neurons than the 20 ng/
ml used in this study (B.A.C. and A.K.H., unpublished
observations), suggesting a ‘‘plateau’’ in responsiveness
occurs at these concentrations. Many small-diameter neurons
were CGRP-immunoreactive in adult cultures, as expected
because this neuropeptide is one hallmark of the nociceptor
population. The majority of CGRP-expressing nociceptors
also express substance P. Interestingly, the proportion of SP-
containing neurons did not change after a skin wound (data
not shown), suggesting that neuropeptides may be differen-
tially regulated in response to a skin wound. Further, the
B.A. Cruise et al. / Developmental Biology 271 (2004) 1–108magnitude of CGRP induction in vitro was larger than that in
vivo, perhaps reflecting the concentration or availability of
the ligand after the skin wound. No difference was seen in
the survival of adult rat DRG neurons that are NGF inde-
pendent for survival even at high concentrations of activin,
or with the addition of both factors together, thus confirming
that activin’s action was on CGRP induction, not selective
survival. Although they do not require NGF for survival,
adult sensory neurons still respond to NGF with limited
neuropeptide increases (this report, Lindsay and Harmar,
1989; Lindsay et al., 1989). The original identity of these
plastic neurons has not been fully established and may differ
in vivo and in vitro. For example, only cutaneous sensory
neurons are likely to be affected by skin changes in vivo,
while the entire sensory population is exposed to activin in
vitro.
While both activin and NGF can increase sensory neuro-
peptides (Ai et al., 1999), these ligands may have different
functions following skin wounds. Previous studies have
shown that activin mRNA increases in skin 1 day after skin
injury and remains elevated for 7 days after wounding
(Hu¨bner et al., 1996), and our data indicate that activin
protein is similarly upregulated after wounding in keratino-
cytes. Activin mRNA has also been detected in mesenchy-
mal cells of the granulation tissue under a scab, as well as in
activated macrophages (Era¨maa et al., 1992; Hu¨bner et al.,
1996). In transgenic mice, overexpression of activin from a
keratin promoter produces a thickened epidermis resulting
from hyperproliferation of keratinocytes (Munz et al.,
1999). Excisional skin injury in these mice resulted in
enhanced granulation tissue formation and enhanced wound
healing. In addition, mice that overexpress the activin
antagonist follistatin have significantly delayed wound heal-
ing (Wankell et al., 2001). Several other members of the
TGFh superfamily stimulate keratinocyte or fibroblast pro-
liferation and other aspects of wound repair (see Choi and
Fuchs, 1990; Hebda, 1988; Roberts and Sporn, 1986), but
these have varied expression in wounded skin. Activin
appears to play a key role in wound repair of adult skin,
and although it is possible that changes in untested members
of the TGFh family could contribute to the observed peptide
changes, increases in skin activin following a wound, along
with its ability to increase neuronal CGRP, make activin a
prime candidate for a role in neuropeptide regulation. A
more important role for NGF after injury may be in the
regulation of cutaneous afferent sprouting (Rajan et al.,
2003). Administration of anti-NGF at the site of injury
reduces sprouting locally and prevents hyperalgesia, sug-
gesting NGF acts in pain responses after injury (Ramer and
Bisby, 1999; Ro et al., 1999; Streppel et al., 2002).
It is reasonable to assume that the activin signal in skin is
transmitted to the neuronal cell body and subsequently
results in CGRP induction, although little is known about
the molecular basis of this signal in neurons. Other target-
derived factors such as NGF generate a retrograde signal in
neurons (Ginty and Segal, 2002) that is thought to reflect asignaling endosome, but whether activin, its receptors, or
associated smad cell signaling moieties are retrogradely
transported is not currently known. Recent pilot data sug-
gest that radiolabeled BMP7 can be retrogradely transported
in sympathetic neurons (Beck et al., 2001), and BMP4
appears to be retrogradely transported from targets in
invertebrate neurons (Allan et al., 2003). Other members
of the TGFh family are internalized along with their
receptors in cultured cell lines to signal to the nucleus
(Panopoulou et al., 2002; Zwaagstra et al., 2001), but
molecular details of activin signaling from axons remain
to be elucidated.
We have identified activin as a new candidate regulator
of sensory vasoactive neuropeptide regulation that induces
CGRP in embryonic neurons and that is strongly upregu-
lated after skin injury in adult sensory neurons. We propose
that during development, limiting amounts of activin in skin
induce a subset of cutaneous sensory neurons to express
CGRP, and this subset of neurons is maintained in the adult.
After adult skin injury, the initial release of vasoactive
sensory neuropeptides at the injury site produces rapid
vasodilation and release of serum factors that are important
for wound healing. It is interesting to speculate that the
mechanism by which target-derived activin induces CGRP
during development may be recapitulated in the adult after
skin injury. These molecules may then trigger activin
expression in skin or blood vessels, which, perhaps in
combination with NGF, induces sensory neurons to increase
their production of vasoactive peptides (feed-forward) and
to regulate wound healing. Thus, to successfully understand
sensory neuronal responses to injury that involve pain and
promote healing, it is crucial to understand the functions of
the TGFh family mediating these biological actions.Acknowledgments
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